chrisvoncsefalvay/vaers-outcomes huggingface dataset:
hardly walk; couldn't get out of bed; felt like she was in a another world like in twilight.; feel tired; incoherence; incontinence; severe weakness/ I was very  weak; inability to verbalize anything; unable to eat; nausea; dehydration; constipated; This is a spontaneous report from a contactable consumer (patient). An 82-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via unknown route of administration on arm (deltoid (upper arm) on 13Mar2021 11:00 (at the age of 82-years-old) as dose 2, single, (Lot number was not reported), intramuscular on arm (deltoid (upper arm) on 19Feb2021 (at the age of 82-years-old) as dose 1, single for covid-19 immunisation. Medical history included ongoing low levels (Drug Name: Vitamin D-Reason for use: low levels). Concomitant medication included colecalciferol (VITAMIN D) for low levels from Jan2021 and ongoing. Caller received both doses of the vaccine. She could hardly walk and could not get out of bed, she felt like she was in another world like in twilight. Caller stated that these symptoms were present with first dose but mainly severe after the second dose. She just feels tired now. All the other symptoms were gone. She heard some lady was very sick and experienced similar side effects as her. She was later hospitalized. Both Vaccines resulted in the onset of incoherence, incontinence, severe weakness, and inability to verbalize anything in 2021. She has only experienced this the two times after the vaccines. She was unable to eat due to nausea, dehydration. In her 82 years of living, she has never wet the bed and was very weak and became constipated. She took extra precautions and made sure she was very well hydrated to prevent outcome of first vaccine. It did not help. Each occurrence lasted about 2 weeks. The treatment not received for events. The outcome of events resolved on 2021.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Fever, chills, dizziness, lack of appetite, pain at injection site, confusion.
mixing error occurred, patient may have been given just diluent. working to find dose to revaccinate
Arm where injection was given was red, hot, and swollen.  Hives were noted on same arm.
Soreness and swelling in right arm, severe joint aches, fatigue, palpitations, severe episodes of vertigo (standing and laying down), GI discomfort followed by loose stools.
The day after the vaccine developed a fine, red itchy rash on both arms and back. Rash went away after 24 hours of it starting. 8 days after the vaccine, developed a raised, hive-like, itchy, sore, warm-to-touch rash over Left upper arm. Rash lasted 24-48 hours.
Patient was given the high dose flu shot instead of Fluarix flu shot in the left Deltoid. Also given the Moderna Bivalent Booster in the left Deltoid. NO adverse side affects noted .
The vaccines were "short dated" and new expiration date of 6/30/2023 was given; Caller reports that they had a temperature excursion 3/31/2023 which they called into the regulatory agency. The vaccines were "short dated" and a new expiration date of 6/30/2023 was given. She states that the products were labeled but still accidentally adminis; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drug reactions or allergies were not reported.   On 31-MAR-2023, a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) (lot # W035470, expiration date reported as 02-MAY-2024,  but upon internal review stablished as 06-MAY-2024) underwent a temperature excursion between 6 up to 14 Fahrenheit (F) for 4 hours, 14 F up to 46 F for 4 hours and 47 F to 77 F (50 F) for 3 hours and 57 minutes for a total time frame of excursion of 11 hours 57 minutes (product storage error). It was reported that due to the temperature excursion, the expiration date of the vaccine was short date to 30-JUN-2023 (product expiration date issue); however, on this date, the patient was accidentally vaccinated with a dose of this vaccine 0.5 mL (route of administration, anatomical location not provided) as prophylaxis. No additional information provided.
Patient presented to the ED and was subsequently hospitalized for acute blood loss anemia within 6 weeks of receiving covid vaccination.
Pt devel fever w/no relief giving APAP, slight difficulty breathing; Encouraged mom to go to ER, no tx given; Back to ER next AM given pediaprofin & Ceclor x 5 days;
Dizziness, unbalance in walking, off awareness, pain in left side of body burning in right side of upper body. Walking instead, vision off. Arm tingling (right). Hearing is affected/ off.
The only long-term problem I am experiencing is a change in my Menstrual Cycle. My periods are suddenly not being controlled as well by my NuvaRing and have become heavier, as well as much more uncomfortable and sometimes painful. I also cannot continue to ?stack? my NuvaRing for 2 consecutive months because I will start bleeding before the second ring is finished being used.
Raised red area measure 2 3/4 inches x 2 1/2 inches. Area itchy.  Noted on 2/15/2021. Vaccine given 2/2/2021.
Immediate metallic taste. It has been 4 weeks since the vaccine and it has not gone away at all.
Vaccine administered at 16:50 17:09 reports of spinning/dizziness.  VS: O298%; BP: 130/82 17:15 BP 140/86 17:20 BP 138/84  Reports no symptoms
I experienced typical immune response symptoms as explained in provided literature and from public sources such as the CDC and my local health department.  In addition to typical symptoms of an immune response (fatigue, headache, muscle aches) that were transient, I also experienced an exceptionally heavy mensuration two weeks after the immunization. This is NOT caused to situational stress or anxiety. I fully expected to be just fine after the immunization, I have no needle phobia, and the vax clinic was in a familiar setting staffed with kind, efficient, and professional volunteers and medical staff. I was with my husband who is a loving, supportive partner.    I assure you that there was no ?psychological? effect that caused heavy menses after the immunization as is stated in much of the news sources; it was not ?all in my head? as the CDC a state health department seem to think. I am quite insulted that this side effect is regarded as such. I though medical professionals could look past Stereotypical ?female histrionics?  and consider this a side effect.  A second unusual symptom I experienced was a lack of control of my temper.  Situations that I would normally  find mildly irritating or slightly frustrating were sources of extreme anger and frustration. This occurred 72-96 hours after the immunization. I didn?t realize this until several days after the exceptional negative reactions.
Chills; body ache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and MYALGIA (body ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills) and MYALGIA (body ache). The patient was treated with PREDNISONE at a dose of 1 dosage form. At the time of the report, CHILLS (Chills) and MYALGIA (body ache) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       treatment medication also included Centroid. Treatment medication Details not provided for 1st dose.
In preparing the vaccines for this patient I misread the combo vaccine we have supplied and in turn gave the patient an extra dose of the IPV vaccine.
Pt Fainted. Pt left Pharmacy area and went up front bought a water at Front register and Fainted while ringing up. Pt cut back of head. Pt said he had not eaten or drank anything all day and was Prone to Fainting. Paramedic called Pt refused to go to Hospital.
Painful ribs ,profound fatigue,- frontal headaches, muscle pain, chills , loss of apatite .joint pain , nausea .
awakened during noc w/vomiting & felt warm per parents; vomiting cont 3-4 times/day x2 days; t99.4 R 48 hrs p/brought for TB test reading & checked parent addressed rxn to shots; also had pimple-like almost like bite appearing skin eruption
Lightheaded and sweaty 3 mins post vaccination Water was provided, patient rested Patient discharged to home
2nd Moderna  Dose administered 3.25.21 also left arm.  Adverse: 1) For months arm felt as if i had been lunched in left arm. 2) Tinnitus began in OCTOBER 2021. Buasing in head. Sometimes mellow; sometimes so loud i was going crazy from it! Awful. Tinnitus has continued off and on now fir months...mostly head buzzing. Sometimes as loud as the train going by on the track next to me. Sometimes as mild as a truck on the freeway four nlock away, but still annoying, like right now.
After patient got home after the imz she felt lightheaded but attributed it to not having eaten yet.  She says the shoulder of imz got red and very hot. She went to sleep early. She woke up in the night to use restroom and experienced extreme vertigo. The next day, patient had diarrhea, fever/chills, arm pain for two days and couldn't keep anything down. She said they were flu-like symptoms. Yesterday was the first day she was symptom free.
Seen for lethargy - pallor. Glucose @ 110. Sent to ER for evaluation and was subsequently admitted for intussusception. 8/8/07-records received for DOS 7/5/07-DX: Intussusception. C/O lethargy and became pale. No nausea no vomiting no diarrhea or blood in stool. Successful reduction with air enema.
This spontaneous report as received from a nurse refers to multiple patients of unknown age and gender. On unknown dates, the patients were vaccinated with improperly stored doses of ROTATEQ for prophylaxis (lot #, expiration date, dose, route and site of administration were not reported). The temperature and time frame of excursions were unknown by reporter. There were also previous unspecified temperature excursions. The Data Logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1707USA000439: US-009507513-1707USA000440: US-009507513-1707USA000441: US-009507513-1707USA000442: US-009507513-1707USA000443:
pt remained in clinic x 10-15min w/no rxn;pt called from home about 1hr later complained dizziness & burning @ temple;pt told to take advil;2hr later pt c/o lt arm & lt side of face w/numbness & tongue feeling swollen;
developed fever on Day 7 and 8 following administration of MMR and Varivax. On the 10th day following administration , he developed a full body reaction known as erythema Multiforme.
Unconsolable crying for over 3 hours. Fever went to 102, some vomiting. Back to normal after 48 hours (was not sick before immunizations).
Information has been received from a healthcare worker concerning a 48 year old male physician with no known allergies, who wears contacts and has high cholesterol and high blood pressure and no history of immune problems who on 12-JUN-2007, was slashed with measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot 655280/1468F) in the eye during administration to a patient. Concomitant therapy included verapamil and Toprol. On 12-JUN-2007, the patient's eye was burning a little bit and he complained of some stinging in eye 4-5 hrs after exposure. There was no redness. As of 12-JUN-2007, the physician had not recovered from his eye burning and stinging. Additional information has been requested.
Hypertension after second vaccine noted. B4 vaccine avg at home bp 115/70,  after vaccine noted as high as 180/90. Avg after vaccine 150/90. Had to go to cardiologist and received medication bystolic 5mg. Gastrointestinal issues: after second dose severe bloating, no bowel movements, could not eat solid food for over 10 days. My primary physician ordered ct scan with contrast. Outcome no blockages or masses. Still bloating but am moving bowels.
Patient noticed a red spot on injection site(left arm), 3X3 inches big,; injection site itchy; injection site warm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Patient noticed a red spot on injection site(left arm), 3X3 inches big,), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE WARMTH (injection site warm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     Concomitant products included VITAMINS;AMINO ACIDS for an unknown indication.    On 21-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 01-Mar-2021, the patient experienced INJECTION SITE ERYTHEMA (Patient noticed a red spot on injection site(left arm), 3X3 inches big,), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE WARMTH (injection site warm). At the time of the report, INJECTION SITE ERYTHEMA (Patient noticed a red spot on injection site(left arm), 3X3 inches big,), INJECTION SITE PRURITUS (injection site itchy) and INJECTION SITE WARMTH (injection site warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Rec'd DTap and IPV in left arm. On 3/27/2006 woke up 3/28/2006 with red, swollen arm. DX with Cellulitis immunization treated with Keflex.
Incorrect storage of drug; Device issue; Fever; Off label use; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), PRODUCT STORAGE ERROR (Incorrect storage of drug), DEVICE ISSUE (Device issue) and OFF LABEL USE (Off label use) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 013F21A) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    Patient had no known allergies.  The patient's past medical history included Non-smoker, Abstains from alcohol and Joint replacement. Concomitant products included MELOXICAM for Arthritis, MONTELUKAST for Asthma and Bronchitis, LOSARTAN for Blood pressure.   In 2019, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram every two weeks. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2019, the patient experienced OFF LABEL USE (Off label use). On 27-Nov-2021, the patient experienced PYREXIA (Fever). On 01-Dec-2021, the patient experienced PRODUCT STORAGE ERROR (Incorrect storage of drug) and DEVICE ISSUE (Device issue). On 02-Dec-2021, PYREXIA (Fever) had resolved. At the time of the report, PRODUCT STORAGE ERROR (Incorrect storage of drug) and DEVICE ISSUE (Device issue) outcome was unknown and OFF LABEL USE (Off label use) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked in.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  In 2019, the patient experienced Off-label use. On 27-Nov-2021, the patient experienced recurring fever. On 01-Dec-2021, the patient experienced pen was out for a little more than 20 minutes/the gray cap was removed, and the end of the pen was broken. On 02-Dec-2021, the recurring fever resolved.  No treatment medication reported.
After my second vaccine, I experienced chills, sweats, headaches, body aches, join pain. I went to Occupational Health due to a large lymph node I also had to my vaccine, which was the size of a lemon. I took Ibuprofen for pain medication and relief of my headaches.
Starting in the early morning of the day after receiving the vaccine, I developed a low grade fever, chills, body aches and severe fatigue. I laid around all day and about 9-10 pm that evening I magically felt fine again.
runny nose; body soreness; altered taste; shaking; generalized weakness; dry mouth; increased mucus production; Occasional headache; Tiredness; Fuzzy feeling; Decreased appetite; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Fuzzy feeling), DECREASED APPETITE (Decreased appetite), RHINORRHOEA (runny nose), PAIN (body soreness) and TASTE DISORDER (altered taste) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2101912) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included RIOCIGUAT (ADEMPAS), APIXABAN (ELIQUIS) and AMLODIPINE.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Fuzzy feeling), DECREASED APPETITE (Decreased appetite), RHINORRHOEA (runny nose), PAIN (body soreness), TASTE DISORDER (altered taste), TREMOR (shaking), ASTHENIA (generalized weakness), DRY MOUTH (dry mouth), SECRETION DISCHARGE (increased mucus production), HEADACHE (Occasional headache) and FATIGUE (Tiredness). At the time of the report, FEELING ABNORMAL (Fuzzy feeling), DECREASED APPETITE (Decreased appetite), RHINORRHOEA (runny nose), PAIN (body soreness), TASTE DISORDER (altered taste), TREMOR (shaking), ASTHENIA (generalized weakness), DRY MOUTH (dry mouth), SECRETION DISCHARGE (increased mucus production), HEADACHE (Occasional headache) and FATIGUE (Tiredness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-102381 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 30-Apr-2021: Duplicate case found MOD-2021-102381. merged documents added.
Pt started itching on face and chest and arms 20 min after injection .Pt started turning red and scratching   , Per NP  give 25mg Benadryl, 4mg Decadron and 40mg depo Medrol IM. and asked to wait to monitor.    Pt was feeling better after shot.
Patient experienced extreme arm swelling, hives/rash on the trunk of the body as well as his arm. Lasted for roughly 10 days after receiving the vaccine.
Bruising, petichiae, heavy bleeding with menstrual period, bloody nose.  We got blood drawn on March 29 and again March 31.  Her blood platelet count was 40 on March 29 and 71 on March 31.  She was diagnosed with idiopathic thrombocytopenia purpura.  No treatment needed at this time since her platelet count is on its way up.
Symptoms: Dizziness, lowered O2 saturation, tachycardia, suprasternal retractions, mottling  of skin on all extremities and torso. Treatment: Oxygen via Nasal cannula applied at 2l, Childrens Benedryl, Decadron and Epi Pen administered. Outcome:  Skin mottling resolved after Epi Pen administered, saturation improved while on oxygen, 911/ambulance called. Left pediatric department in stable condition being transported to Childrens Hosp.
No treatment given. Feels sharp pain in deltoid of left side when rotation/reaching cannot sleep o0n left deltoid. Is woken up from sleep by mild throbbing in deltoid left. (Injection site). Pain scale 2-3- No other apparent problems.
not received 2nd dose; This case was reported by a other health professional via interactive digital media and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st doseon 23rd October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter asked, what should the patient needed to do.
4/19 I developed severe hives/rash all over my skin and inside my throat. I felt weak and tired. My throat was also swollen. This reaction is still continuing today 4/30, and I do  not know when it will end. I have been to urgent care twice for steroids, I have taken Benadryl, and Zyrtec but nothing will fully get rid of the reaction. I visited an allergist on 4/29 and she believes that I am having an adverse reaction to the vaccine. She prescribed several antihistamines to counter my reaction to the vaccine, including bendaryl, famotidine, fexofenadine, zyrtec, and an epipen incase my throat starts to close.
Varicella like rash on left shoulder and upper back. No other rash. No fever. No URI symptoms. No treatment necessary.
flare of inflammation go through several body parts; condition aggravated; Initial information received on 03-Jan-2022 regarding an unsolicited valid non-serious social media case received from a patient.   This case involves an unknown age and unknown gender patient who had flare of inflammation go through several body parts while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  In OCT-2021, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer via unknown route in unknown administration site (dose, formulation, strength, lot number and expiry date: not reported) as prophylactic vaccination.  On an unknown date, the patient developed a non-serious event "flare of inflammation go through several body parts" (inflammation) with symptom condition aggravated (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "When I worked in health care, all the staff got their jab so we could protect our residents. I hadn't had a flu shot for a few years & then decided to get one in October of 2021, because Covid is still hanging around. I had a flare of inflammation go through several body parts. Had never had a reaction from a flu vaccine before."  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (flare of inflammation go through several body parts).  At time of reporting, the outcome was Unknown for the event flare of inflammation go through several body parts.